Identification and characterisation of a novel anti-viral peptide against avian influenza virus H9N2

Virology Journal

Volumn 6, Issue , 2009, Pages

  Rajik, Mohamed ^a   Jahanshiri, Fatemeh ^a   Omar, Abdul Rahman ^a   Ideris, Aini ^a   Hassan, Sharifah Syed ^b   Yusoff, Khatijah ^a  

^a UNIVERSITY PUTRA MALAYSIA   (Malaysia)

^b MONASH UNIVERSITY MALAYSIA   (Malaysia)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARAGINYLASPARTYLPHENYLALANYLARGINYLSERYLLYSYLTHREONINE; CYSTEINYLASPARAGINYLASPARTYLPHENYLALANYLARGINYLSERYLLYSYLTHREONYLCYSTEINE; CYSTEINYLSERYLTRYPTOPHYLGLYCYLGLUTAMYLTYROSYLASPARTYLMETHIONYLCYSTEINE; HEMAGGLUTININ; OLIGONUCLEOTIDE; POLYPEPTIDE ANTIBIOTIC AGENT; SIALIDASE; UNCLASSIFIED DRUG; VIRUS ANTIBODY; ANTIVIRUS AGENT; HEMAGGLUTININ FUSOGENIC PEPTIDE, INFLUENZA VIRUS; PEPTIDE; PEPTIDE LIBRARY; VIRUS HEMAGGLUTININ;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIVIRAL ACTIVITY; ARTICLE; AVIAN INFLUENZA VIRUS; BINDING AFFINITY; BINDING SITE; CONTROLLED STUDY; DRUG IDENTIFICATION; DRUG SYNTHESIS; ENZYME ACTIVITY; HEMAGGLUTINATION; HEMOLYSIS; IMMUNOPRECIPITATION; INFLUENZA VIRUS; NONHUMAN; SEQUENCE ANALYSIS; VIRUS REPLICATION; VIRUS STRAIN; WESTERN BLOTTING; ANIMAL; CELL LINE; CELL SURVIVAL; DOG; DRUG EFFECT; DRUG SCREENING; INFLUENZA VIRUS A H9N2; METABOLISM; PROTEIN BINDING; TWO HYBRID SYSTEM;

AVES; AVIAN INFLUENZA VIRUS; HUMAN INFLUENZA VIRUS; SPONDIAS PURPUREA;

ANIMALS; ANTIVIRAL AGENTS; CELL LINE; CELL SURVIVAL; DOGS; DRUG EVALUATION, PRECLINICAL; HEMAGGLUTININS, VIRAL; INFLUENZA A VIRUS, H9N2 SUBTYPE; PEPTIDE LIBRARY; PEPTIDES; PROTEIN BINDING; TWO-HYBRID SYSTEM TECHNIQUES;

EID: 67949111077     PISSN: None     EISSN: 1743422X     Source Type: Journal    
DOI: 10.1186/1743-422X-6-74     Document Type: Article

References (41)

1. Orthomyxoviruses. BR Murphy RG Webster, Field's Virology Philadelphia: Lippincott-Raven Publishers, Fields BN, Knipe DM, Howley PM, 1996 1397 1445
2. Characterization of a novel influenza A virus hemagglutinin subtype (H16) obtained from black-headed gulls. RA Fouchier V Munster A Wallensten TM Bestebroer S Herfst D Smith GF Rimmelzwaan B Olsen AD Osterhaus, J Virol 2005 79 2814 2822 15709000
3. Recent epidemiology and ecology of influenza A viruses in avian species in Europe and the Middle East. IH Brown J Banks RJ Manvell SC Essen W Shell M Slomka B Londt DJ Alexander, Dev Biol (Basel) 2006 124 45 50 16447493
4. Natural cases and an experimental study of H9N2 avian influenza in commercial broiler chickens of Iran. H Nili K Asasi, Avian Pathol 2002 31 247 252 12396348
5. Human infection with an avian H9N2 influenza A virus in Hong Kong in 2003. KM Butt GJ Smith H Chen LJ Zhang YH Leung KM Xu W Lim RG Webster KY Yuen JS Peiris, J Clin Microbiol 2005 43 5760 5767 16272514
6. Avian-to-human transmission of H9N2 subtype influenza A viruses: relationship between H9N2 and H5N1 human isolates. YP Lin M Shaw V Gregory K Cameron W Lim A Klimov K Subbarao Y Guan S Krauss K Shortridge, Proc Natl Acad Sci USA 2000 97 9654 9658 10920197
7. Human infection with influenza H9N2. M Peiris KY Yuen CW Leung KH Chan PL Ip RW Lai WK Orr KF Shortridge, Lancet 1999 354 916 917 10489954
8. Replication and transmission of H9N2 influenza viruses in ferrets: evaluation of pandemic potential. H Wan EM Sorrell H Song MJ Hossain G Ramirez-Nieto I Monne J Stevens G Cattoli I Capua LM Chen, PLoS ONE 2008 3 e2923 18698430
9. Influenza. KG Nicholson JM Wood M Zambon, Lancet 2003 362 1733 1745 14643124
10. Ion channel activity of influenza A virus M2 protein: characterization of the amantadine block. C Wang K Takeuchi LH Pinto RA Lamb, J Virol 1993 67 5585 5594 7688826
11. Neuraminidase inhibitors for influenza. A Moscona, N Engl J Med 2005 353 1363 1373 16192481
12. Adamantane resistance among influenza A viruses isolated early during the 2005-2006 influenza season in the United States. RA Bright DK Shay B Shu NJ Cox AI Klimov, JAMA 2006 295 891 894 16456087
13. Susceptibility of highly pathogenic A(H5N1) avian influenza viruses to the neuraminidase inhibitors and adamantanes. AC Hurt P Selleck N Komadina R Shaw L Brown IG Barr, Antiviral Res 2007 73 228 231 17112602
14. Respiratory viral threats. FG Hayden, Current Opinion in Infectious Diseases 2006 19 169 178 16514342
15. Influenza virus antigenic variation, host antibody production and new approach to control epidemics. J Chen YM Deng, Virol J 2009 6 30 19284639
16. Oseltamivir resistance during treatment of influenza A (H5N1) infection. MD de Jong TT Thanh TH Khanh VM Hien GJD Smith NV Chau BV Cam PT Qui DQ Ha Y Guan, New England Journal of Medicine 2005 353 2667 2672 16371632
17. Avian flu: isolation of drug-resistant H5N1 virus. QM Le M Kiso K Someya YT Sakai TH Nguyen KH Nguyen ND Pham HH Ngyen S Yamada Y Muramoto, Nature 2005 437 1108 16228009
18. Molecular characterization of the complete genome of human influenza H5N1 virus isolates from Thailand. P Puthavathana P Auewarakul PC Charoenying K Sangsiriwut P Pooruk K Boonnak R Khanyok P Thawachsupa R Kijphati P Sawanpanyalert, J Gen Virol 2005 86 423 433 15659762
19. Biotechnological applications of phage and cell display. I Benhar, Biotechnol Adv 2001 19 1 33 14538090
20. Random peptide libraries: a source of specific protein binding molecules. JJ Devlin LC Panganiban PE Devlin, Science 1990 249 404 406 2143033
21. Binding to protein targets of peptidic leads discovered by phage display: crystal structures of streptavidin-bound linear and cyclic peptide ligands containing the HPQ sequence. BA Katz, Biochemistry 1995 34 15421 15429 7492542
22. A new type of synthetic peptide library for identifying ligand-binding activity. KS Lam SE Salmon EM Hersh VJ Hruby WM Kazmierski RJ Knapp, Nature 1991 354 82 84 1944576
23. A phage display system designed to detect and study protein-protein interactions. CL Bair A Oppenheim A Trostel G Prag S Adhya, Mol Microbiol 2008 67 719 728 18179417
24. Structure-activity relationships of a peptide inhibitor of the human FcRn:human IgG interaction. AR Mezo KA McDonnell A Castro C Fraley, Bioorg Med Chem 2008 16 6394 6405 18501614
25. Novel peptides that inhibit the propagation of Newcastle disease virus. P Ramanujam WS Tan S Nathan K Yusoff, Arch Virol 2002 147 981 993 12021868
26. Biological evaluation of anti-influenza viral activity of semi-synthetic catechin derivatives. JM Song KD Park KH Lee YH Byun JH Park SH Kim JH Kim BL Seong, Antiviral Res 2007 76 178 185 17709148
27. Amyloid-beta binds to the extracellular cysteine-rich domain of Frizzled and inhibits Wnt/beta-catenin signaling. MH Magdesian MM Carvalho FA Mendes LM Saraiva MA Juliano L Juliano J Garcia-Abreu ST Ferreira, J Biol Chem 2008 283 9359 9368 18234671
28. Structural diversity of bicyclic amino acids. A Trabocchi D Scarpi A Guarna, Amino Acids 2008 34 1 24 17701095
29. Competition among peptides in melanoma vaccines for binding to MHC molecules. LW Thomson CI Garbee S Hibbitts CH Brinckerhoff RA Pierce KA Chianese-Bullock DH Deacon VH Engelhard JrCL Slingluff, J Immunother 2004 27 425 431 15534486
30. Peptide inhibition of HIV-1: current status and future potential. N Kaushik-Basu A Basu D Harris, BioDrugs 2008 22 161 175 18481899
31. Peptide inhibitors of dengue virus and West Nile virus infectivity. YM Hrobowski RF Garry SF Michael, Virol J 2005 2 49 15927084
32. Developing antiangiogenic peptide drugs for angiogenesis-related diseases. KN Sulochana R Ge, Curr Pharm Des 2007 13 2074 2086 17627540
33. Inhibition of influenza virus infection by a novel antiviral peptide that targets viral attachment to cells. JC Jones EA Turpin H Bultmann CR Brandt S Schultz-Cherry, J Virol 2006 80 11960 11967 17005658
34. Orthomyxoviridae: The viruses and their replication. RA Lamb RM Krug, Field's Virology Philadelphia: Raven Publishers, Fields BN, Knipe DM, Howley PM, 1996 1353 1395
35. Effect of hemagglutinin glycosylation on influenza virus susceptibility to neuraminidase inhibitors. VP Mishin D Novikov FG Hayden LV Gubareva, J Virol 2005 79 12416 12424 16160169
36. Cleavage activation of influenza virus hemagglutinin and its role in pathogenesis. W Garten HD Klenk, Avian Influenza Basel: Karger, Klenk H-D, Matrosovich MN, Stech J, 2008 156 167
37. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. MM Bradford, Anal Biochem 1976 72 248 254 942051
38. J Sambrook EF Fritsch T Maniatis, Moelcular Cloning: A laboratory manual New York: Cold Spring Harbor Laboratories Press 1989
39. Libraries of peptides and proteins displayed on filamentous phage. GP Smith JK Scott, Methods Enzymol. 1993 217 228 257 7682645
40. Influenzavirus neuraminidase and neuraminidase-inhibition test procedures. M Aymard-Henry MT Coleman WR Dowdle WG Laver GC Schild RG Webster, Bull World Health Organ 1973 48 199 202 4541685
41. FM Ausubel R Breat RE Kingston DD Moore JG Seidman JA Smith, Current Protocols in Molecular Biology New York: Wiley 1994